HAIM
Hunter Associates Investment Management Portfolio holdings
AUM
$756M
1-Year Est. Return
19.99%
This Fund
S&P 500
1 Year Est. Return
+19.99%
AUM
$756M
AUM Growth
+$7.83M
(+1%)
Holding
282
Top Buys
| 1 | +$5.26M | |
| 2 | +$2.53M | |
| 3 | +$2.2M | |
| 4 |
Babcock & Wilcox
BW
|
+$2.14M |
| 5 |
LMRI
Lumexa Imaging Holdings
LMRI
|
+$1.96M |
Top Sells
| 1 | +$3.26M | |
| 2 | +$2.22M | |
| 3 | +$1.93M | |
| 4 |
Expedia Group
EXPE
|
+$1.3M |
| 5 |
Global X NASDAQ-100 Covered Call ETF
QYLD
|
+$1.09M |
Sector Composition
| 1 | Technology | 21.2% |
| 2 | Healthcare | 10.93% |
| 3 | Industrials | 8.54% |
| 4 | Financials | 6.12% |
| 5 | Consumer Discretionary | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Advanced Micro Devices
AMD
$842B
| – | – |
-1,197
|
|
||
277
CME Group
CME
$98.8B
| – | – |
-978
|
|
||
278
CrowdStrike
CRWD
$186B
| – | – |
-508
|
|
||
279
Darling Ingredients
DAR
$9.39B
| – | – |
-7,750
|
|
||
280
Pentair
PNR
$11.4B
| – | – |
-2,266
|
|
||
281
Qualcomm
QCOM
$265B
| – | – |
-1,961
|
|
||
282
Zevra Therapeutics
ZVRA
$685M
| – | – |
-13,260
|
|